These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26298165)

  • 1. Impact of Lepidic Component Occupancy on Effects of Adjuvant Chemotherapy for Lung Adenocarcinoma.
    Sasada S; Miyata Y; Mimae T; Mimura T; Okada M
    Ann Thorac Surg; 2015 Dec; 100(6):2079-86. PubMed ID: 26298165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of Lepidic Component Predominance to Adjuvant Chemotherapy with Oral Fluoropyrimidines for Stage I Lung Adenocarcinoma.
    Sasada S; Miyata Y; Mimae T; Tsutani Y; Mimura T; Okada M
    Clin Lung Cancer; 2016 Sep; 17(5):433-440.e1. PubMed ID: 26725850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma.
    Tsutani Y; Miyata Y; Mimae T; Kushitani K; Takeshima Y; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2013 Sep; 146(3):580-5. PubMed ID: 23778085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival.
    Warth A; Muley T; Meister M; Stenzinger A; Thomas M; Schirmacher P; Schnabel PA; Budczies J; Hoffmann H; Weichert W
    J Clin Oncol; 2012 May; 30(13):1438-46. PubMed ID: 22393100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant Chemotherapy Improves the Probability of Freedom From Recurrence in Patients With Resected Stage IB Lung Adenocarcinoma.
    Hung JJ; Wu YC; Chou TY; Jeng WJ; Yeh YC; Hsu WH
    Ann Thorac Surg; 2016 Apr; 101(4):1346-53. PubMed ID: 26794883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indications for sublobar resection of clinical stage IA radiologic pure-solid lung adenocarcinoma.
    Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
    J Thorac Cardiovasc Surg; 2017 Sep; 154(3):1100-1108. PubMed ID: 28629842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The percentage of lepidic growth is an independent prognostic factor in invasive adenocarcinoma of the lung.
    Strand TE; Rostad H; Strøm EH; Hasleton P
    Diagn Pathol; 2015 Jul; 10():94. PubMed ID: 26159539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second predominant subtype predicts outcomes of intermediate-malignant invasive lung adenocarcinoma†.
    Ito M; Miyata Y; Yoshiya T; Tsutani Y; Mimura T; Murakami S; Ito H; Nakayama H; Okada M
    Eur J Cardiothorac Surg; 2017 Feb; 51(2):218-222. PubMed ID: 28186287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage IB lung adenocarcinoma.
    Qian F; Yang W; Wang R; Xu J; Wang S; Zhang Y; Jin B; Yu K; Han B
    J Thorac Cardiovasc Surg; 2018 Mar; 155(3):1227-1235.e2. PubMed ID: 29223834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Is adjuvant chemotherapy necessary for the peripherally located stage I adenocarcinoma of the lung?].
    Ohta S; Hirose M; Ishibashi H; Muro H
    Kyobu Geka; 2007 Jul; 60(7):519-22; discussion 522-5. PubMed ID: 17642210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Role of Subtype Classification in Small-Sized Pathologic N0 Invasive Lung Adenocarcinoma.
    Yoshiya T; Mimae T; Tsutani Y; Tsubokawa N; Sasada S; Miyata Y; Kushitani K; Takeshima Y; Murakami S; Ito H; Nakayama H; Okada M
    Ann Thorac Surg; 2016 Nov; 102(5):1668-1673. PubMed ID: 27344277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonpredominant lepidic pattern correlates with better outcome in invasive lung adenocarcinoma.
    Mäkinen JM; Laitakari K; Johnson S; Mäkitaro R; Bloigu R; Lappi-Blanco E; Kaarteenaho R
    Lung Cancer; 2015 Dec; 90(3):568-74. PubMed ID: 26506915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease.
    Kadota K; Villena-Vargas J; Yoshizawa A; Motoi N; Sima CS; Riely GJ; Rusch VW; Adusumilli PS; Travis WD
    Am J Surg Pathol; 2014 Apr; 38(4):448-60. PubMed ID: 24472852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of histological components with tumor invasion in pulmonary adenocarcinoma.
    Moon Y; Kim KS; Sung SW; Lee KY; Kim YK; Kang JH; Kim YS; Park JK
    World J Surg Oncol; 2014 Dec; 12():388. PubMed ID: 25519483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of malignant grade between pure and partially invasive types of early lung adenocarcinoma.
    Sasada S; Nakayama H; Miyata Y; Tsubokawa N; Mimae T; Yoshiya T; Murakami S; Ito H; Okada M
    Ann Thorac Surg; 2015 Mar; 99(3):956-60. PubMed ID: 25620597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification on death and recurrence in completely resected stage I lung adenocarcinoma.
    Hung JJ; Jeng WJ; Chou TY; Hsu WH; Wu KJ; Huang BS; Wu YC
    Ann Surg; 2013 Dec; 258(6):1079-86. PubMed ID: 23532112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic and predictive value of the novel classification of lung adenocarcinoma in patients with stage IB.
    Luo J; Huang Q; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Wang Y; Zheng J; Wu H; Xia W; Chen H
    J Cancer Res Clin Oncol; 2016 Sep; 142(9):2031-40. PubMed ID: 27379889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma.
    Kadota K; Sima CS; Arcila ME; Hedvat C; Kris MG; Jones DR; Adusumilli PS; Travis WD
    Am J Surg Pathol; 2016 Dec; 40(12):1579-1590. PubMed ID: 27740967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender, Age, and Comorbidity Status Predict Improved Survival with Adjuvant Chemotherapy Following Lobectomy for Non-small Cell Lung Cancers Larger than 4 cm.
    Sandler BJ; Wang Z; Hancock JG; Boffa DJ; Detterbeck FC; Kim AW
    Ann Surg Oncol; 2016 Feb; 23(2):638-45. PubMed ID: 26474557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors and clinical outcome in patients with surgically resected peripheral N0 adenocarcinoma <3 cm.
    Luzzi L; Marulli G; DE Palma A; Meniconi F; Ghisalberti M; Stocca F; Pagliarulo V; Loizzi M; Rea F; Gotti G
    Minerva Chir; 2016 Feb; 71(1):1-7. PubMed ID: 26149520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.